In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis.

导出 OA

翻译打印收藏纠错

作者： Susanne G,Kidd ^[1] ; Mari,Bogaard ^[2] ; Kristina T,Carm ^[1] ; Anne Cathrine,Bakken ^[2] ; Aase M V,Maltau ^[3] ; Marthe,Løvf ^[1] ; Ragnhild A,Lothe ^[1] ; Karol,Axcrona ^[1] ; Ulrika,Axcrona ^[1] ; Rolf I,Skotheim ^[1]

作者单位： Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Norway. ^[1] Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Norway. ^[2] Department of Pathology, Oslo University Hospital-Radiumhospitalet, Norway. ^[3] Department of Urology, Akershus University Hospital, Lørenskog, Norway. ^[4] Department of Informatics, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway. ^[5]

关键词 ERG ETS biomarker heterogeneity prognosis prostate cancer

主题词人类(Humans);男(雄)性(Male);前瞻性研究(Prospective Studies);前列腺切除术(Prostatectomy);前列腺肿瘤(Prostatic Neoplasms);RNA(RNA);反式激活因子类(Trans-Activators)

DOI 10.1002/1878-0261.13225

PMID 35574900

发布时间 2022-08-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交